The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2023, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $5.31 B in revenue, representing 15.56% of its total revenue.
- Product generated $28.81 B in revenue, representing 84.44% of its total revenue.
The
biggest segment for Eli Lilly and Company is the Product, which represents 84.44% of its total revenue.
The
smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 15.56% of its total revenue.
The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2024, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $4.29 B in revenue, representing 9.53% of its total revenue.
- Product generated $40.75 B in revenue, representing 90.47% of its total revenue.
The
biggest segment for Eli Lilly and Company is the Product, which represents 90.47% of its total revenue.
The
smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 9.53% of its total revenue.
The above chart shows Eli Lilly and Company's revenue percentage share by segment (products and services).
In fiscal year 2025, Eli Lilly and Company's revenue by segment is as follows:
- Collaboration and Other Revenue generated $4.22 B in revenue, representing 6.48% of its total revenue.
- Product generated $60.96 B in revenue, representing 93.52% of its total revenue.
The
biggest segment for Eli Lilly and Company is the Product, which represents 93.52% of its total revenue.
The
smallest segment for Eli Lilly and Company is the Collaboration and Other Revenue, which represents 6.48% of its total revenue.
Submit Feedback
